CHARLES B HAASER Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CHARLES B HAASER.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CHARLES B HAASER. CHARLES B HAASER is Principal Accounting Officer in ABIOMED INC ($ABMD) and Principal Financial Officer in ABIOMED INC ($ABMD) and Chief Accounting Officer in METABOLIX, INC. ($MBLX) and VP Fin & Chief Accting Officer in METABOLIX, INC. ($MBLX).

Latest Insider Trading Transactions of CHARLES B HAASER

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ABMD, MBLX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 03 2021	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Grant	A	16.03	1,950	31,259	4,725	2.8 K to 4.7 K (+70.27 %)
Feb 16 2021	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Payment of Exercise	F	22.77	693	15,780	2,775	3.5 K to 2.8 K (-19.98 %)
Feb 16 2021	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Payment of Exercise	F	22.77	693	15,780	2,775	3.5 K to 2.8 K (-19.98 %)
Jan 27 2021	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Option Exercise	A	16.49	11,500	189,635	11,500
Aug 13 2020	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Payment of Exercise	F	6.55	587	3,845	3,468	4.1 K to 3.5 K (-14.48 %)
May 29 2020	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Option Exercise	A	5.86	21,000	123,060	21,000
May 23 2019	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Option Exercise	A	0.90	60,000	54,000	60,000
Apr 03 2019	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Payment of Exercise	F	1.16	245	284	2,276	2.5 K to 2.3 K (-9.72 %)
May 25 2018	MBLX	YIELD10 BIOSCIENCE ...	HAASER CHARLES B	VP Fin & Chief Acct ...	Option Exercise	A	1.65	100,000	165,000	100,000
Oct 28 2016	MBLX	METABOLIX, INC.	HAASER CHARLES B	VP Fin & Chief Acct ...	Option Exercise	A	0.53	500,000	265,000	500,000
Apr 05 2016	MBLX	METABOLIX, INC.	HAASER CHARLES B	Chief Accounting Of ...	Payment of Exercise	F	1.86	4,217	7,844	30,565	34.8 K to 30.6 K (-12.12 %)
Apr 03 2015	MBLX	METABOLIX, INC.	HAASER CHARLES B	Chief Accounting Of ...	Grant	A	0.00	170,000	0	208,698	38.7 K to 208.7 K (+439.30 %)
Apr 03 2015	MBLX	METABOLIX, INC.	HAASER CHARLES B	Chief Accounting Of ...	Grant	A	0.00	37,698	0	38,698	1,000 to 38.7 K (+3,769.80 %)
Jun 02 2006	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Accountin ...	Option Exercise	M	5.11	1,500	7,665	3,500
Jun 02 2006	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Accountin ...	Sell	S	13.36	1,500	20,046	2,379	3.9 K to 2.4 K (-38.67 %)
Jun 02 2006	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Accountin ...	Buy	M	5.11	1,500	7,665	3,879	2.4 K to 3.9 K (+63.05 %)
Feb 10 2006	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Accountin ...	Option Exercise	M	4.84	5,000	24,220	0
Feb 10 2006	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Accountin ...	Sell	S	10.25	5,000	51,250	2,379	7.4 K to 2.4 K (-67.76 %)
Feb 10 2006	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Accountin ...	Buy	M	4.84	5,000	24,220	7,379	2.4 K to 7.4 K (+210.17 %)
Jun 10 2005	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Financial ...	Option Exercise	A	9.36	20,000	187,200	20,000
Mar 01 2005	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Financial ...	Option Exercise	A	10.80	12,500	135,000	0
Jul 06 2004	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Financial ...	Option Exercise	A	12.30	15,000	184,500	15,000
Jul 06 2004	ABMD	ABIOMED INC	HAASER CHARLES B	Principal Financial ...	Option Exercise	A	5.11	5,000	25,550	5,000

Page: 1